Proteomics of cell-free breast cancer scaffolds identify clinically relevant imprinted proteins and cancer-progressing properties

Anna Gustafsson; Emma Jonasson; Anders Ståhlberg; Göran Landberg

doi:10.1002/cac2.12542

Cancer Communications ›› 2024, Vol. 44 ›› Issue (6) :695 -699. DOI: 10.1002/cac2.12542

LETTER TO THE JOURNAL

Proteomics of cell-free breast cancer scaffolds identify clinically relevant imprinted proteins and cancer-progressing properties

Author information +

History +

PDF

Cite this article

Download citation ▾

Anna Gustafsson, Emma Jonasson, Anders Ståhlberg, Göran Landberg. Proteomics of cell-free breast cancer scaffolds identify clinically relevant imprinted proteins and cancer-progressing properties. Cancer Communications, 2024, 44(6): 695-699 DOI:10.1002/cac2.12542

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Onkar SS, Carleton NM, Lucas PC, Bruno TC, Lee AV, Vignali DAA, et al. The Great Immune Escape: Understanding the Divergent Immune Response in Breast Cancer Subtypes. Cancer Discov. 2023;13(1):23-40.

[2]	Landberg G, Fitzpatrick P, Isakson P, Jonasson E, Karlsson J, Larsson E, et al. Patient-derived scaffolds uncover breast cancer promoting properties of the microenvironment. Biomaterials. 2020;235:119705.

[3]	Leiva MC, Garre E, Gustafsson A, Svanström A, Bogestål Y, Håkansson J, et al. Breast cancer patient-derived scaffolds as a tool to monitor chemotherapy responses in human tumor microenvironments. J Cell Physiol. 2021;236(6):4709-24.

[4]	Persson E, Gregersson P, Gustafsson A, Fitzpatrick P, Rhost S, Ståhlberg A, et al. Patient-derived scaffolds influence secretion profiles in cancer cells mirroring clinical features and breast cancer subtypes. Cell Commun Signal. 2021;19(1):66.

[5]	Salerno S, Ståhlberg A, Holdfeldt A, Bexe Lindskog E, Landberg G. 5-fluorouracil treatment of patient-derived scaffolds from colorectal cancer reveal clinically critical information. J Transl Med. 2022;20(1):209.

[6]	Karantza V. Keratins in health and cancer: more than mere epithelial cell markers. Oncogene. 2011;30(2):127-38.

[7]	Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, et al. Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling. Cell. 2009;139(5):891-906.

[8]	Xu S, Xu H, Wang W, Li S, Li H, Li T, et al. The role of collagen in cancer: from bench to bedside. J Transl Med. 2019;17(1):309.

[9]	Tan Q, Xu L, Zhang J, Ning L, Jiang Y, He T, et al. Breast cancer cells interact with tumor-derived extracellular matrix in a molecular subtype-specific manner. Biomater Adv. 2023;146:213301.